איקסל 25 מג ישראל - עברית - Ministry of Health

איקסל 25 מג

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

רמסימה 100 מג תוך-ורידי ישראל - עברית - Ministry of Health

רמסימה 100 מג תוך-ורידי

padagis israel agencies ltd, israel - infliximab - אבקה להכנת תמיסה מרוכזת לעירוי - infliximab 100 mg/vial - infliximab

זולג'נסמה ישראל - עברית - Ministry of Health

זולג'נסמה

novartis israel ltd - onasemnogene abeparvovec - תרחיף - onasemnogene abeparvovec 2 x 10^13 vg / 1 ml - onasemnogene abeparvovec

אלפו-קל XL ישראל - עברית - Ministry of Health

אלפו-קל xl

padagis israel agencies ltd, israel - alfuzosin hydrochloride - טבליות בשחרור ממושך - alfuzosin hydrochloride 10 mg - alfuzosin - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy, particularly if surgery has to be delayed for some reason.

פרו-קיור 5 מג ישראל - עברית - Ministry of Health

פרו-קיור 5 מג

merck sharp & dohme israel ltd - finasteride - טבליה - finasteride 5 mg - finasteride - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to: reduce the risk of acute urinary retention. reduce the risk of surgery including transurethral resection of the prostate (turp)and prostatectomy. pro-cure causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with pro-cure.

פינסטרייד אינובמד 5 מ"ג ישראל - עברית - Ministry of Health

פינסטרייד אינובמד 5 מ"ג

inovamed ltd - finasteride - film coated tablets - finasteride - for the treatment and control of benign prostatic hyperplasia (bph) and for the prevention of urologic events to reduce the risk of acute urinary retention.reduce the risk of surgery including transurethral resection of the prostate (turp) and prostatectomy. this product causes regression of the enlarged prostate, improves urinary flow and improves the symptoms assocciated with bph. patients with an enlarged prostate are the appropriate candidates for therapy with this product.

נבלבין 20 מג ישראל - עברית - Ministry of Health

נבלבין 20 מג

padagis israel agencies ltd, israel - vinorelbine as tartrate - קפסולות - vinorelbine as tartrate 20 mg - vinorelbine - vinorelbine - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer.

אימיוסיסט ישראל - עברית - Ministry of Health

אימיוסיסט

medici ltd - bcg 81 mg/vial - powder for reconstitution - bcg vaccine - for the treatment of superficial transitional cell carcinoma (tcc) of the urinary bladder, regardless of antecedent intravesical treatment superficial tcc comprises the following: carcinoma in situ (cis), papillary tumors limited to the mucosa (stage ta), papillary tumors invoiving the lamina propria but not the muscle layer of the bladder (stage t1), or any combination thereof. immucyst is indicated for treatment and prophylaxis of primary or recurrent carcinoma insitu (cis) of the urinary bladder and for prophylaxis following trans-urethral resection (tur) of primary or recurrent stage ta and/or t1 papilary tumors.

דואוטרב ישראל - עברית - Ministry of Health

דואוטרב

novartis israel ltd - timolol as maleate; travoprost - תמיסה לעין - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

קונבניה וטרינרי ישראל - עברית - Ministry of Health

קונבניה וטרינרי

pfizer pharmaceuticals israel ltd - cefovicin as sodium salt 80 mg/dose - powder for solution for injection - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp. as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp.cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.